Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 369

1.

Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies.

Perera VN, Nachamkin I, Ung H, Patterson JH, McConville MJ, Coloe PJ, Fry BN.

FEMS Immunol Med Microbiol. 2007 Jun;50(1):27-36. Epub 2007 Mar 21.

2.

Ganglioside mimicry as a cause of Guillain-Barré syndrome.

Komagamine T, Yuki N.

CNS Neurol Disord Drug Targets. 2006 Aug;5(4):391-400. Review.

PMID:
16918391
3.

Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.

Koga M, Gilbert M, Li J, Koike S, Takahashi M, Furukawa K, Hirata K, Yuki N.

Neurology. 2005 May 10;64(9):1605-11.

PMID:
15883324
4.

Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.

Funakoshi K, Koga M, Takahashi M, Hirata K, Yuki N.

J Neurol Sci. 2006 Jul 15;246(1-2):163-8.

PMID:
16600306
5.

Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.

Koga M, Takahashi M, Masuda M, Hirata K, Yuki N.

Neurology. 2005 Nov 8;65(9):1376-81. Epub 2005 Sep 14.

PMID:
16162859
6.

The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barré syndrome.

Xiang SL, Zhong M, Cai FC, Deng B, Zhang XP.

J Neuroimmunol. 2006 May;174(1-2):126-32. Epub 2006 Mar 6.

PMID:
16567003
8.

TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.

Kuijf ML, Samsom JN, van Rijs W, Bax M, Huizinga R, Heikema AP, van Doorn PA, van Belkum A, van Kooyk Y, Burgers PC, Luider TM, Endtz HP, Nieuwenhuis EE, Jacobs BC.

J Immunol. 2010 Jul 1;185(1):748-55. doi: 10.4049/jimmunol.0903014. Epub 2010 Jun 4.

9.
10.
12.

Association of Anti-GT1a Antibodies with an Outbreak of Guillain-Barré Syndrome and Analysis of Ganglioside Mimicry in an Associated Campylobacter jejuni Strain.

Zhang M, Gilbert M, Yuki N, Cao F, Li J, Liu H, Li Q, Meng F, Zhang J.

PLoS One. 2015 Jul 21;10(7):e0131730. doi: 10.1371/journal.pone.0131730. eCollection 2015.

13.

BAFF aids generation of IgG anti-ganglioside antibodies in response to Campylobacter jejuni lipo-oligosaccharide.

Matsumoto Y, Kobata T, Odaka M, Furukawa K, Hirata K, Yuki N.

J Neuroimmunol. 2010 Jan 25;218(1-2):67-72. doi: 10.1016/j.jneuroim.2009.10.010. Epub 2009 Nov 6.

PMID:
19896222
14.

Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.

Koga M, Gilbert M, Li J, Yuki N.

PLoS One. 2015 Apr 13;10(4):e0124004. doi: 10.1371/journal.pone.0124004. eCollection 2015.

15.

Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.

Islam Z, Gilbert M, Mohammad QD, Klaij K, Li J, van Rijs W, Tio-Gillen AP, Talukder KA, Willison HJ, van Belkum A, Endtz HP, Jacobs BC.

PLoS One. 2012;7(8):e43976. doi: 10.1371/journal.pone.0043976. Epub 2012 Aug 27.

16.

Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.

Koga M, Gilbert M, Takahashi M, Li J, Koike S, Hirata K, Yuki N.

J Infect Dis. 2006 Feb 15;193(4):547-55. Epub 2006 Jan 19.

PMID:
16425134
17.
18.

Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy.

Goodfellow JA, Bowes T, Sheikh K, Odaka M, Halstead SK, Humphreys PD, Wagner ER, Yuki N, Furukawa K, Furukawa K, Plomp JJ, Willison HJ.

J Neurosci. 2005 Feb 16;25(7):1620-8.

19.

Brucella melitensis infection associated with Guillain-Barré syndrome through molecular mimicry of host structures.

Watanabe K, Kim S, Nishiguchi M, Suzuki H, Watarai M.

FEMS Immunol Med Microbiol. 2005 Aug 1;45(2):121-7. Epub 2005 Mar 24.

20.

Human gangliosides and bacterial lipo-oligosaccharides in the development of autoimmune neuropathies.

Yuki N.

Methods Mol Biol. 2010;600:51-65. doi: 10.1007/978-1-60761-454-8_4. Review.

PMID:
19882120

Supplemental Content

Support Center